How big is Foghorn Therapeutics, Inc.?

Jun 22 2025 06:10 PM IST
share
Share Via
As of Jun 18, Foghorn Therapeutics, Inc. has a market capitalization of 267.00 million and reported net sales of 23.51 million with a net profit of -80.43 million over the last four quarters. Shareholder's funds are at -45.53 million, and total assets amount to 458.37 million.
As of Jun 18, Foghorn Therapeutics, Inc. has a market capitalization of 267.00 million, categorizing it as a Micro Cap company.

As of Jun 18, the sum of net sales for the latest four quarters is 23.51 million, while the sum of net profit for the same period is -80.43 million.

As of Dec 24, the shareholder's funds are reported at -45.53 million, and the total assets amount to 458.37 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Foghorn Therapeutics, Inc. overvalued or undervalued?
Sep 20 2025 06:32 PM IST
share
Share Via
Is Foghorn Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 09:12 AM IST
share
Share Via
What does Foghorn Therapeutics, Inc. do?
Jun 22 2025 06:55 PM IST
share
Share Via